UniProt ID | FAK2_MOUSE | |
---|---|---|
UniProt AC | Q9QVP9 | |
Protein Name | Protein-tyrosine kinase 2-beta | |
Gene Name | Ptk2b | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1009 | |
Subcellular Localization |
Cytoplasm. Cytoplasm, perinuclear region. Cell membrane Peripheral membrane protein Cytoplasmic side. Cell junction, focal adhesion. Cell projection, lamellipodium. Cytoplasm, cell cortex. Nucleus. Colocalizes with integrins at the cell periphery ( |
|
Protein Description | Non-receptor protein-tyrosine kinase that regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading and bone remodeling. Plays a role in the regulation of the humoral immune response, and is required for normal levels of marginal B-cells in the spleen and normal migration of splenic B-cells. Required for normal macrophage polarization and migration towards sites of inflammation. Regulates cytoskeleton rearrangement and cell spreading in T-cells, and contributes to the regulation of T-cell responses. Promotes osteoclastic bone resorption; this requires both PTK2B/PYK2 and SRC. May inhibit differentiation and activity of osteoprogenitor cells. Functions in signaling downstream of integrin and collagen receptors, immune receptors, G-protein coupled receptors (GPCR), cytokine, chemokine and growth factor receptors, and mediates responses to cellular stress. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Promotes activation of NOS3. Regulates production of the cellular messenger cGMP. Promotes activation of the MAP kinase signaling cascade, including activation of MAPK1/ERK2, MAPK3/ERK1 and MAPK8/JNK1. Promotes activation of Rho family GTPases, such as RHOA and RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Acts as a scaffold, binding to both PDPK1 and SRC, thereby allowing SRC to phosphorylate PDPK1 at 'Tyr-9, 'Tyr-373', and 'Tyr-376' (By similarity). Promotes phosphorylation of NMDA receptors by SRC family members, and thereby contributes to the regulation of NMDA receptor ion channel activity and intracellular Ca(2+) levels. May also regulate potassium ion transport by phosphorylation of potassium channel subunits. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ASAP1, NPHP1, KCNA2 and SHC1. Promotes phosphorylation of ASAP2, RHOU and PXN; this requires both SRC and PTK2/PYK2 (By similarity).. | |
Protein Sequence | MSGVSEPLSRVKVGTLRRPEGPPEPMVVVPVDVEKEDVRILKVCFYSNSFNPGKNFKLVKCTVQTEIQEIITSILLSGRIGPNIQLAECYGLRLKHMKSDEIHWLHPQMTVGEVQDKYECLHVEAEWRYDLQIRYLPEDFMESLKEDRTTLLYFYQQLRNDYMQRYASKVSEGMALQLGCLELRRFFKDMPHNALDKKSNFELLEKEVGLDLFFPKQMQENLKPKQFRKMIQQTFQQYASLREEECVMKFFNTLAGFANIDQETYRCELIQGWNITVDLVIGPKGIRQLTSQDTKPTCLAEFKQIKSIRCLPLEETQAVLQLGIEGAPQSLSIKTSSLAEAENMADLIDGYCRLQGEHKGSLIMHAKKDGEKRNSLPQIPTLNLEARRSHLSESCSIESDIYAEIPDETLRRPGGPQYGVAREEVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTQDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVPTLVLYTLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPELCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDIYQMEKDIAIEQERNARYRPPKILEPTTFQEPPPKPSRPKYRPPPQTNLLAPKLQFQVPEGLCASSPTLTSPMEYPSPVNSLHTPPLHRHNVFKRHSMREEDFIRPSSREEAQQLWEAEKIKMKQVLERQQKQMVEDSQWLRREERCLDPMVYMNDKSPLTPEKEAGYTEFTGPPQKPPRLGAQSIQPTANLDRTDDLVYHNVMTLVEAVLELKNKLGQLPPEDYVVVVKNVGLNLRKLIGSVDDLLPSLPASSRTEIEGTQKLLNKDLAELINKMKLAQQNAVTSLSEDCKRQMLTASHTLAVDAKNLLDAVDQAKVVANLAHPPAE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSGVSEPLS ------CCCCCCCCC | 60.24 | 30635358 | |
5 | Phosphorylation | ---MSGVSEPLSRVK ---CCCCCCCCCCCE | 36.70 | 23737553 | |
9 | Phosphorylation | SGVSEPLSRVKVGTL CCCCCCCCCCEEECC | 45.82 | 23737553 | |
15 | Phosphorylation | LSRVKVGTLRRPEGP CCCCEEECCCCCCCC | 21.78 | 26824392 | |
162 | Phosphorylation | YQQLRNDYMQRYASK HHHHHHHHHHHHHHH | 9.94 | 28576409 | |
166 | Phosphorylation | RNDYMQRYASKVSEG HHHHHHHHHHHCCHH | 9.80 | 26643407 | |
168 | Phosphorylation | DYMQRYASKVSEGMA HHHHHHHHHCCHHHH | 25.34 | 26643407 | |
171 | Phosphorylation | QRYASKVSEGMALQL HHHHHHCCHHHHHHH | 31.97 | 26643407 | |
361 | Phosphorylation | LQGEHKGSLIMHAKK CCCCCCCCEEEEECC | 21.37 | - | |
375 | Phosphorylation | KDGEKRNSLPQIPTL CCCCCCCCCCCCCCC | 45.52 | 24925903 | |
381 | Phosphorylation | NSLPQIPTLNLEARR CCCCCCCCCCHHHHH | 29.88 | 28833060 | |
389 | Phosphorylation | LNLEARRSHLSESCS CCHHHHHHHCCCCCC | 24.19 | 29899451 | |
392 | Phosphorylation | EARRSHLSESCSIES HHHHHHCCCCCCCCC | 23.26 | 29899451 | |
394 | Phosphorylation | RRSHLSESCSIESDI HHHHCCCCCCCCCCE | 15.13 | 25367039 | |
396 | Phosphorylation | SHLSESCSIESDIYA HHCCCCCCCCCCEEE | 38.37 | 29899451 | |
399 | Phosphorylation | SESCSIESDIYAEIP CCCCCCCCCEEEECC | 27.86 | 29899451 | |
402 | Phosphorylation | CSIESDIYAEIPDET CCCCCCEEEECCCHH | 11.81 | 20442405 | |
418 | Phosphorylation | RRPGGPQYGVAREEV CCCCCCCCCCCHHHH | 19.39 | 25367039 | |
440 | Phosphorylation | EGFFGEVYEGVYTNH CCCCCEEEEEEEECC | 11.58 | 22817900 | |
571 | Phosphorylation | KLGDFGLSRYIEDED ECCCCCCCCCCCCCC | 24.34 | 22817900 | |
573 | Phosphorylation | GDFGLSRYIEDEDYY CCCCCCCCCCCCCCH | 12.80 | 20116462 | |
579 | Phosphorylation | RYIEDEDYYKASVTR CCCCCCCCHHEECEE | 12.57 | 25521595 | |
580 | Phosphorylation | YIEDEDYYKASVTRL CCCCCCCHHEECEEC | 16.64 | 25521595 | |
583 | Phosphorylation | DEDYYKASVTRLPIK CCCCHHEECEECCCC | 21.62 | 22324799 | |
585 | Phosphorylation | DYYKASVTRLPIKWM CCHHEECEECCCCCC | 24.80 | 25367039 | |
722 | Phosphorylation | PKPSRPKYRPPPQTN CCCCCCCCCCCCCCC | 30.91 | 25159016 | |
746 | Phosphorylation | VPEGLCASSPTLTSP CCCCCCCCCCCCCCC | 35.53 | 27087446 | |
747 | Phosphorylation | PEGLCASSPTLTSPM CCCCCCCCCCCCCCC | 11.90 | 21659605 | |
749 | Phosphorylation | GLCASSPTLTSPMEY CCCCCCCCCCCCCCC | 44.61 | 26160508 | |
751 | Phosphorylation | CASSPTLTSPMEYPS CCCCCCCCCCCCCCC | 33.01 | 26160508 | |
752 | Phosphorylation | ASSPTLTSPMEYPSP CCCCCCCCCCCCCCC | 25.92 | 26160508 | |
756 | Phosphorylation | TLTSPMEYPSPVNSL CCCCCCCCCCCCCCC | 11.62 | 21659605 | |
758 | Phosphorylation | TSPMEYPSPVNSLHT CCCCCCCCCCCCCCC | 40.35 | 21659605 | |
762 | Phosphorylation | EYPSPVNSLHTPPLH CCCCCCCCCCCCCCC | 23.05 | 27087446 | |
765 | Phosphorylation | SPVNSLHTPPLHRHN CCCCCCCCCCCCCCC | 31.71 | 27087446 | |
778 | Phosphorylation | HNVFKRHSMREEDFI CCCHHHHCCCHHHCC | 24.46 | 23684622 | |
834 | Phosphorylation | RCLDPMVYMNDKSPL HHCCCEEECCCCCCC | 5.50 | 25367039 | |
839 | Phosphorylation | MVYMNDKSPLTPEKE EEECCCCCCCCCCHH | 28.18 | 25367039 | |
842 | Phosphorylation | MNDKSPLTPEKEAGY CCCCCCCCCCHHCCC | 32.55 | 28725479 | |
849 | Phosphorylation | TPEKEAGYTEFTGPP CCCHHCCCCCCCCCC | 15.33 | 18515860 | |
850 | Phosphorylation | PEKEAGYTEFTGPPQ CCHHCCCCCCCCCCC | 24.57 | 25521595 | |
853 | Phosphorylation | EAGYTEFTGPPQKPP HCCCCCCCCCCCCCC | 42.41 | 25367039 | |
866 | Phosphorylation | PPRLGAQSIQPTANL CCCCCCCCCCCCCCC | 23.74 | - | |
881 | Phosphorylation | DRTDDLVYHNVMTLV CCCCCHHHHHHHHHH | 8.58 | 15705590 | |
956 | Acetylation | DLAELINKMKLAQQN HHHHHHHHHHHHHHH | 30.34 | 2416637 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
402 | Y | Phosphorylation | Kinase | PTK2B | Q9QVP9 | GPS |
402 | Y | Phosphorylation | Kinase | SRC | P05480 | PSP |
579 | Y | Phosphorylation | Kinase | LCK | P06240 | GPS |
579 | Y | Phosphorylation | Kinase | LYN | P25911 | GPS |
579 | Y | Phosphorylation | Kinase | SRC | P05480 | GPS |
580 | Y | Phosphorylation | Kinase | FYN | P39688 | Uniprot |
580 | Y | Phosphorylation | Kinase | LCK | P06240 | Uniprot |
580 | Y | Phosphorylation | Kinase | LYN | P25911 | GPS |
580 | Y | Phosphorylation | Kinase | SRC | P05480 | Uniprot |
881 | Y | Phosphorylation | Kinase | SRC | P05480 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FAK2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FAK2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SRC_MOUSE | Src | physical | 14739300 | |
DOK1_MOUSE | Dok1 | physical | 10823839 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND MASSSPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND MASSSPECTROMETRY. | |
"Comprehensive identification of phosphorylation sites in postsynapticdensity preparations."; Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R.,Burlingame A.L.; Mol. Cell. Proteomics 5:914-922(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND MASSSPECTROMETRY. | |
"Hypophosphorylated and inactive Pyk2 associates with paxillin at themicrotubule organizing center in hematopoietic cells."; St-Pierre J., Lysechko T.L., Ostergaard H.L.; Cell. Signal. 23:718-730(2011). Cited for: INTERACTION WITH PXN, SUBCELLULAR LOCATION, AND PHOSPHORYLATION ATTYR-402; TYR-580 AND TYR-881. | |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-440, AND MASSSPECTROMETRY. | |
"Quantitative time-resolved phosphoproteomic analysis of mast cellsignaling."; Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y.,Kawakami T., Salomon A.R.; J. Immunol. 179:5864-5876(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-402; TYR-579 ANDTYR-580, AND MASS SPECTROMETRY. | |
"Src kinase activity is essential for osteoclast function."; Miyazaki T., Sanjay A., Neff L., Tanaka S., Horne W.C., Baron R.; J. Biol. Chem. 279:17660-17666(2004). Cited for: FUNCTION IN BONE RESORPTION, INTERACTION WITH SRC, PHOSPHORYLATION ATTYR-402, AND MUTAGENESIS OF TYR-402. | |
"Nephrocystin interacts with Pyk2, p130(Cas), and tensin and triggersphosphorylation of Pyk2."; Benzing T., Gerke P., Hoepker K., Hildebrandt F., Kim E., Walz G.; Proc. Natl. Acad. Sci. U.S.A. 98:9784-9789(2001). Cited for: PHOSPHORYLATION AT TYR-402, AND INTERACTION WITH NPHP1. | |
"Different modes and qualities of tyrosine phosphorylation of Fak andPyk2 during epithelial-mesenchymal transdifferentiation and cellmigration: analysis of specific phosphorylation events using site-directed antibodies."; Nakamura K., Yano H., Schaefer E., Sabe H.; Oncogene 20:2626-2635(2001). Cited for: PHOSPHORYLATION AT TYR-402; TYR-580 AND TYR-881. |